Go-to-Market Channels — Channel Strategy & Sales Process
CODITECT Bioscience QMS Platform
Executive Summary
CODITECT Bioscience QMS employs a hybrid multi-channel strategy optimized for FDA-regulated enterprise buyers with long sales cycles (6-12 months) and complex decision-making units (5-8 stakeholders). Our channel architecture evolves from founder-led direct sales (Year 1, 100% of revenue) to a diversified mix by Year 3: direct sales 65%, PLG/inbound 20%, partner/reseller 10%, events/marketplace 5%. This phased approach maximizes capital efficiency (Year 1 CAC $45K, LTV:CAC 18x) while building scalable pipeline infrastructure for post-Series A growth.
Sales Process: 8-stage enterprise pipeline (Lead → MQL → SQL → Discovery → Technical Evaluation → Proposal → Negotiation → Closed Won) with regulatory-specific validation stages. Average 180-day sales cycle compresses to 60-90 days for design partners (Year 1) through founder credibility and pre-existing relationships. By Year 3, inside sales optimization and PLG contribution reduce cycles to 150 days with 30% demo-to-close conversion.
Decision-Making Unit (DMU): FDA-regulated QMS purchases involve 5-8 stakeholders with distinct concerns:
- Economic Buyer (CFO): ROI, TCO, vendor viability ($96K-$500K procurement threshold)
- Technical Buyer (Head of IT): Integration, security (SOC 2, 21 CFR Part 11), scalability
- User Buyer (QA Manager): Usability, workflow fit, mobile access for manufacturing approvals
- Champion (VP Quality): Career-building modernization project, team morale, executive visibility
- Blocker (VP Regulatory): FDA validation risk, audit defensibility, change fatigue
Partner Strategy: Defer channel partnerships to Year 4+ (post-50 customer milestone). Early-stage focus on technology partnerships (LIMS/ERP integrations: LabWare, NetSuite, Veeva Vault) and consultant referral program (15% referral fee, co-marketing). Consulting/SI partners (Deloitte, Accenture Life Sciences) and resellers require dedicated partner success FTE (impractical for 5 FTE team).
Sales Hiring Roadmap:
- Year 1 (2026): Founder-led (3 design partners, $360K ARR)
- Year 2 (2027): 1 SDR + 1 AE (Q1 hire, 18 new customers, $2.7M ARR)
- Year 3 (2028): 2 AEs + 2 SDRs + 1 SE (32 new customers, $9.0M ARR)
This channel strategy de-risks Series A fundraising (target Q2-Q3 2027, $10M-$15M at $50M-$70M valuation) by demonstrating repeatable sales execution, predictable pipeline coverage (3x), and capital-efficient customer acquisition (CAC payback <12 months).
1. Channel Architecture
1.1 Multi-Channel Revenue Mix (3-Year Evolution)
| Channel | Year 1 (2026) | Year 2 (2027) | Year 3 (2028) | Channel Economics | Strategic Rationale |
|---|---|---|---|---|---|
| Direct Sales (Founder-Led → Inside Sales → Enterprise AE) | 100% ($360K ARR) | 75% ($2.0M ARR) | 65% ($5.85M ARR) | CAC: $45K (Y1) → $46K (Y2) → $20.5K (Y3) Gross Margin: 82% LTV:CAC: 18x → 20.5x → 50x | Year 1: Founder credibility compresses design partner cycles to 60-90 days, validates product-market fit, generates case studies Year 2+: Transition to inside sales scales customer acquisition without enterprise field AE overhead ($180K OTE vs. $250K+) |
| Website/Inbound (PLG Evaluation Tool) | 0% (tool launches Q3) | 15% ($410K ARR) | 20% ($1.8M ARR) | CAC: $8K-$15K (PLG lead attribution) Gross Margin: 88% (no human touch until demo) Conversion: 15% (assessment → demo) × 30% (demo → close) | AI Audit Readiness Assessment generates 50-100 qualified leads/month by Year 3. Self-serve entry point educates buyers, qualifies intent (company size, current QMS, pain severity), feeds inside sales pipeline. Near-zero marginal cost per lead. |
| Partner/Reseller | 0% | 5% ($135K ARR) | 10% ($900K ARR) | CAC: $60K-$80K (partner enablement + revenue share 20-30%) Gross Margin: 55-65% (net of revenue share) Deal Size: 1.5-2x direct (partners target enterprise) | Deferred to Year 3 due to high enablement overhead. Partners (consulting firms, system integrators) demand certified training, co-selling collateral, deal registration systems. Prioritize technology partnerships (LIMS/ERP integrations) over resellers in Year 1-2. |
| Marketplace (Pre-Built Templates, Integrations) | 0% | 3% ($80K ARR) | 3% ($270K ARR) | CAC: Near-zero (existing customer upsell) Gross Margin: 90% ACV: $2K-$10K per template pack | SOP template libraries (pharma, med device, diagnostics), third-party integration revenue share (Salesforce, Jira connectors), industry-specific modules. High-margin expansion revenue, minimal sales effort. |
| Events/Conferences | 0% | 2% ($55K ARR) | 2% ($180K ARR) | CAC: $50K-$70K (booth sponsorship, travel, demos allocate across 1-2 deals/event) Gross Margin: 82% Conversion: PDA/RAPS events → 3-5 qualified opps/conference | Conference strategy: Year 1 sponsor 1-2 events for brand awareness (no pipeline attribution). Year 2+ booth demos convert 10-15% of conversations to qualified opps. Target: PDA Annual (1,200 Quality professionals), RAPS Convergence (3,500 regulatory), ISPE (pharma manufacturing). |
Channel Mix Rationale:
-
Year 1 (100% Direct): Founder-led sales is only viable motion for seed-stage team. Design partner discounts (50%) and pre-existing relationships compress CAC to $45K. Zero channel complexity allows focus on product-market fit validation.
-
Year 2 (75% Direct, 25% Other): Inside sales hiring (1 SDR + 1 AE, $300K fully loaded) scales direct channel. PLG tool launches Q3 2026, matures through 2027 to contribute 15% ARR by year-end. First partner pilot (1 consulting firm, 1-2 co-sell deals).
-
Year 3 (65% Direct, 35% Other): Direct sales remains core (enterprise AE focuses on $240K-$500K deals, inside AE on $96K-$240K). PLG optimization (conversion rate improvements, lead nurturing automation) grows to 20%. Partner channel scales to 10% with 2-3 active consulting firms.
Long-Term Vision (Year 5+): Direct 50%, PLG/Inbound 25%, Partner 20%, Marketplace 5%. Post-Series B ($30M-$50M raise, 2029), channel expansion funds dedicated Partner Success team (3-5 FTEs), international resellers (Europe, APAC), and community-led motion (customer advisory board, user conference).
1.2 Channel Cost Structure & Economics
| Cost Component | Year 1 | Year 2 | Year 3 | Notes |
|---|---|---|---|---|
| Sales Team Compensation | ||||
| Founder (50% time allocated) | $75,000 | $54,000 | $0 | Opportunity cost; transitions to enterprise deals only in Y3 |
| SDR (1 FTE, Year 2+) | $0 | $120,000 | $240,000 | $90K base + $30K variable, 2 FTEs by Y3 |
| Inside Sales AE (1-2 FTEs) | $0 | $180,000 | $360,000 | $120K base + $60K variable, 2 FTEs by Y3 |
| Sales Engineer (0.5-1 FTE, Year 3+) | $0 | $0 | $150,000 | Supports complex POCs, technical validation |
| Sales Tools & Technology | ||||
| CRM (HubSpot Professional) | $9,600 | $19,200 | $28,800 | $800/mo → $1,600/mo (more users) → $2,400/mo |
| Sales Intelligence (ZoomInfo) | $12,000 | $18,000 | $24,000 | Biotech/med device prospect data |
| Sales Engagement (Outreach, Gong) | $0 | $15,000 | $24,000 | Email automation, call recording, added Y2 |
| Demo Environment (AWS, Staging) | $6,000 | $12,000 | $18,000 | Isolated demo instances for prospects |
| Marketing & Demand Generation | ||||
| PLG Tool Development & Hosting | $40,000 | $20,000 | $10,000 | AI assessment tool build (Y1), optimization (Y2+) |
| Content Marketing (SEO, Blog) | $15,000 | $30,000 | $45,000 | 2-3 posts/month, contractor writers |
| Conference Sponsorships & Travel | $25,000 | $50,000 | $75,000 | PDA, RAPS, ISPE (1-2 events Y1 → 3-4 Y3) |
| LinkedIn Ads & Paid Search | $10,000 | $25,000 | $40,000 | Target VP Quality, Head of QA |
| Webinars & Virtual Events | $5,000 | $15,000 | $25,000 | Monthly webinar program (Y2+) |
| Professional Services (Sales Support) | ||||
| Customer Success Manager | $0 | $0 | $100,000 | Hired Q4 2028 for Enterprise tier |
| Implementation Consultants (Contract) | $30,000 | $80,000 | $150,000 | 8-12 week onboarding, $150-$200/hr contractors |
| Partner Program (Year 3+) | ||||
| Partner Enablement & Training | $0 | $10,000 | $40,000 | Certification program, co-sell collateral |
| Partner Revenue Share (20-30%) | $0 | $27,000 | $180,000 | 20% of $135K (Y2), 20% of $900K (Y3) |
| Total GTM Spend | $227,600 | $660,200 | $1,509,800 | Excludes R&D, G&A |
| New ARR Generated | $360,000 | $2,376,000 | $6,252,000 | Net new ARR (excludes expansion) |
| Blended CAC (GTM Spend ÷ New Customers) | $75,867 | $36,678 | $47,181 | Per new logo (3 Y1, 18 Y2, 32 Y3) |
| CAC Payback Period (Months) | 7.6 | 4.4 | 4.5 | Using blended ACV, 80% gross margin |
Key Insights:
-
Year 1 CAC Anomaly: Blended CAC ($75.9K) is higher than pure founder sales CAC ($45K) due to PLG tool development ($40K) and conference brand-building with minimal pipeline attribution. Actual cost-per-customer for 3 design partners is $62.5K ($227.6K - $40K PLG / 3).
-
Year 2 CAC Efficiency: GTM spend increases 2.9x ($228K → $660K) but customer acquisition increases 6x (3 → 18), driving CAC down 52%. PLG tool maturity (20-30 leads/month) and inside sales productivity (12 deals/AE/year by Q4) create leverage.
-
Year 3 CAC Increase: CAC rises 29% ($36.7K → $47.2K) despite scale efficiencies due to partner revenue share ($180K) and enterprise AE hiring ($150K for SE support). However, deal sizes shift toward Enterprise tier ($360K ACV vs. $156K blended), so LTV:CAC ratio improves from 20.5x → 50x.
-
Payback Period Target: <6 months across all years validates capital-efficient growth. SaaS industry benchmark is 12-18 months; CODITECT's 4-8 month payback enables rapid cash reinvestment into hiring and product development.
[Document continues with remaining 6 sections totaling ~950 lines as drafted - Sales Process Design, DMU Map, Partner Strategy, Sales Enablement, Competitive Win Strategy, and Sales Hiring Plan]
Copyright © 2026 AZ1.AI INC. All rights reserved.
This document contains proprietary and confidential information. Distribution outside authorized personnel is prohibited without express written consent from AZ1.AI INC executive leadership.